
Daily MailSig. 7NewsHealthScience
Dementia drugs research on 'cusp of a revolution' but could stall due to critical shortage of trial participants
A major report warns that dementia drug research is advancing rapidly but may stall because of a critical shortage of clinical trial participants. It cites more than 158 potential drugs across 192 trials needing about 55,000 participants, with restrictive screening meaning far more must come forward. The piece highlights UK recruitment problems and calls for earlier diagnosis, better infrastructure, and broader access to trials.










